A new medical breakthrough shows promise for millions of Americans with Type 1 diabetes, who may be able to get their insulin using an inhaler instead of traditional injections. Vance: Iranian leaders ...
The FDA has approved the first fast-acting inhaled insulin for children with Type 1 diabetes, offering an alternative to daily injections. Iran and Israel halt strikes after unprecedented retaliation ...
The Food and Drug Administration on Friday approved Afrezza, an inhaled needle-free insulin, for children with diabetes. It is the first needle-free insulin option for children. Fifteen-year-old Greg ...
Researchers from the University of Geneva (UNIGE) and Geneva University Hospitals (HUG) have reached a significant advance in the fight against type 1 diabetes. Using an innovative hydrogel that ...
Please provide your email address to receive an email when new articles are posted on . The Control-IQ+ automated insulin delivery system was approved for use in pregnancy with the t:slim X2 and Mobi ...
*A gene therapy that may eliminate, or significantly reduce, the need for daily insulin injections is preparing to enter human trials for the first time, offering fresh hope to hundreds of thousands ...
Insulin, a hormone medication used to regulate blood sugar, has long been one of the most important therapies for managing type 2 diabetes. But with the rise of semaglutide (Ozempic) and other ...
Insulin icodec-abae (Awiqli; Novo Nordisk) is now approved for use in the US, Canada, European Union, Switzerland, and 12 other countries. Its indication is as an adjunct to diet and exercise for ...
The FDA approval of Awiqli is a ‘huge deal’ for people looking for an alternative to daily shots, experts say. The FDA just approved Awiqli, a once-weekly insulin treatment for type 2 diabetes. Awiqli ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark ...
What Is Awiqli, and Why Does It Matter? Awiqli (insulin icodec-abae) is a once-weekly long-acting basal insulin injection approved by the FDA for adults with type 2 diabetes. It helps lower blood ...
The FDA approved insulin icodec (Awiqli) as the first once-weekly, long-acting basal insulin for glycemic control in adults with type 2 diabetes, developer Novo Nordisk announced. Of note, the agency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results